Michael Morin, left, and David Frazier, right, of Latham & Watkins.
Latham & Watkins global IP co-chair Michael Morin and partner David Frazier delivered a save worth billions to clients Janssen Biotech Inc. and Genmab A/S.
February 08, 2019 at 12:09 PM
1 minute read
Editor and columnist at The Litigation Daily
The Litigator of the Week crown goes to a Latham & Watkins global IP co-chair Michael Morin and partner David Frazier, who delivered a save worth billions to clients Janssen Biotech Inc. and Genmab A/S.
Janssen (which is part of Johnson & Johnson) and Genmab were sued for patent infringement by competitor MorphoSys AG, represented by Kirkland & Ellis. At issue: IP rights to blood cancer drug Darzalex, which Genmab invented and Janssen licensed and markets.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
